

Request Sample Report
The Full Service Contract Research Organization (CRO) market is expanding rapidly, driven by increasing pharmaceutical and biotechnology R&D investments. The market size is projected to reach approximately $60 billion by 2026, fueled by rising outsourcing trends and demand for integrated clinical trial services across various therapeutic areas. Request Sample Report
◍ Labcorp
◍ IQVIA
◍ Parexel
◍ Syneos Health
◍ PRA Health Sciences
◍ PPD
◍ ICON
◍ MedPace
◍ Wuxi AppTec
The Full Service CRO Market is driven by increasing R&D spending and demand for clinical trials. Key players include Labcorp, IQVIA, Parexel, Syneos Health, PRA Health Sciences, PPD, ICON, Medpace, and Wuxi AppTec, providing end-to-end services that enhance efficiency and reduce costs, fostering market growth. Notable revenues:
- Labcorp: $14 billion
- IQVIA: $13.1 billion
- Parexel: $2.6 billion
- Icon: $4.3 billion. Request Sample Report
Pharmaceutical
Bio-pharm
Others
Request Sample Report
Phase I Trial
Phase II Trial
Phase III Trial
Phase IV Trial
Request Sample Report
$ X Billion USD